41
|
|
|
TATA-box binding protein associated factor 9 |
MGC:5067, STAF31/32, TAF2G, TAFII-31, TAFII-32, TAFII31, TAFII32, TAFIID32 |
|
42
|
|
|
TATA-box binding protein associated factor 9b |
DN-7, DN7, TAF9L, TAFII31L, TFIID-31 |
|
43
|
|
|
TAFA chemokine like family member 1 |
FAM19A1, TAFA-1 |
|
44
|
|
|
TAFA chemokine like family member 2 |
FAM19A2, TAFA-2 |
Anorexia nervosa, Anxiety disorder, Asthma, Central nervous system cancer, Obstructive pulmonary disease, Cognition disorder, Dementia, Digestive system disease, Eating disorder, Glioblastoma, Glioma, Obesity, Obsessive-compulsive disorder, Peripheral neuropathy, Seasonal allergic rhinitis |
45
|
|
|
TAFA chemokine like family member 4 |
FAM19A4, TAFA-4 |
|
46
|
|
|
TAFA chemokine like family member 5 |
FAM19A5, QLLK5208, TAFA-5, UNQ5208 |
Alzheimer disease, Attention deficit hyperactivity disorder, Bipolar disorder, Breast cancer, Cannabis abuse, Endometrial cancer, Endometrial neoplasms, Gastroesophageal reflux disease, Glomerulonephritis, Iga nephropathy, Insomnia, Iron metabolism disorder, Lymphedema, Male reproductive organ cancer, Metabolic syndrome, Ocular sarcoidosis, Pancreatic cancer, Psychiatric disorders, Psychotic disorders, Schizophrenia, Scoliosis, Substance abuse, Diabetes mellitus type 2, Venous thromboembolismView all (9 more) |
47
|
|
|
Tafazzin, phospholipid-lysophospholipid transacylase |
BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, TAZ, Taz1 |
|
48
|
|
|
T cell activation RhoGTPase activating protein |
ARHGAP47, FKSG15, IDDM21, TAGAP1 |
Ankylosing spondylitis, Rheumatoid arthritis, Eczema, Autoimmune disease, Celiac disease, Crohn disease, Dermatitis, Hypothyroidism, Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis, Psoriasis, Psoriasis vulgaris, Sclerosing cholangitis, Systemic lupus erythematosus, Diabetes mellitus type 1, Diabetes mellitus type 2, Ulcerative colitisView all (3 more) |
49
|
|
|
Transgelin |
SM22, SM22-alpha, SMCC, TAGLN1, TGLN, WS3-10 |
|
50
|
|
|
Transgelin 2 |
HA1756 |
|